Home » Authors » Donna Young

Donna Young

Articles

ARTICLES

NewCo News: BioVascular, Revitus Merge To Tackle Vascular Problems

Sep. 11, 2007

NewCo News: BioVascular, Revitus Merge To Tackle Vascular Problems

Sep. 11, 2007

FDA Panel to Evaluate Anemia Drug Dosing

Sep. 10, 2007

FDA Panel to Evaluate Anemia Drug Dosing

Sep. 10, 2007

Waxman Says Any Biosimilar Pathway 'Must Be Rigorous'

Sep. 7, 2007

Waxman Says Any Biosimilar Pathway 'Must Be Rigorous'

Sep. 7, 2007

BDSI, Meda Partner On $90M+ Licensing Deal For Opioid Disc

Sep. 6, 2007

BioDelivery Sciences International Inc. is set to receive $30 million in an up-front payment from Swedish specialty pharma Meda AB under a licensing agreement for BEMA Fentanyl, a dissolvable opioid disc product. (BioWorld Today)

BDSI, Meda Partner On $90M+ Licensing Deal For Opioid Disc

Sep. 6, 2007

BioDelivery Sciences International Inc. is set to receive $30 million in an up-front payment from Swedish specialty pharma Meda AB under a licensing agreement for BEMA Fentanyl, a dissolvable opioid disc product. (BioWorld Today)

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Sep. 5, 2007

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Sep. 5, 2007

View All Articles by Donna Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...